Navigation Links
Adrenal Suppression not predicted by inhaled corticosteroids

It is proved beyond doubt that asthma is affected beneficially by long-term treatment with inhaled corticosteroids (ICS) in childhood//.

Although there is a lot of side affects that are associated with it. Which include adrenal suppression and growth deceleration; continue to be of concern to physicians that treat asthmatic children.

The main researchers were Kostas N. Priftis (Department of Allergology-Pulmonology, Penteli Children's Hospital, P. Penteli, Greece) and colleagues from Cyprus and Greece. They studied if impairment of growth of these children can predict adrenal function suppression.

To test the hypothesis low dose synacthen test was performed in 72 asthmatic children on long-term treatment (6-84 months) with low to moderate doses of inhaled budesonide. The parameters studied were changes in height standard deviation scores (HSDS) at the time of testing and height velocity SDS (HVSDS) in the preceding year were also calculated.

Adrenal suppression was demonstrated in 15 asthmatic children (20.8%) but this was only a biochemical finding. There was no correlation between adrenal response and dose or duration of treatment. However, a positive relation between HVSDS and duration of treatment was noted.

As a conclusion it is said that long-term treatment of asthmatic children with low to moderate doses of inhaled budesonide may result in mild adrenal suppression that can not be predicted by growth deceleration.

Durationg increase has a negative effect on the children.
'"/>




Page: 1

Related medicine news :

1. Genetic Link to Adrenal Tumor Revealed
2. Adrenaline Associated With Adventurers Risk Taking
3. Stock of Adrenaline Runs Out, in New Zealand Hospitals
4. Targeting the Adrenal Gland Could Be Key Against Heart Failure
5. Transplant Cures Rats’ Type 2 Diabetes without Need for Immune Suppression Drug
6. Long-time Gastric Acid Suppression Does Not Increase The Risk Of Cancer
7. Suppression of Enzyme Delays a Type of Breast Cancer
8. Should Menstrual Suppression Be a Lifestyle Choice?
9. Epilepsy can be predicted
10. Effect of Osteosarcoma predicted by scans
11. Periodontal disease can be predicted by trends in obesity!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... ... May 04, 2016 , ... Safety ... global construction firms representing the Construction Industry Safety Initiative (CISI) and the Incident ... purpose: to inspire everyone in the industry to be leaders in safety. Statistics ...
(Date:5/3/2016)... ... May 04, 2016 , ... The National Association ... into its VIP Woman of the Year Circle. She is recognized with this prestigious ... professional women, boasting more than 850,000 members and over 200 operating Local Chapters. , ...
(Date:5/3/2016)... ... May 03, 2016 , ... According to an article ... issues related to medical care in the hospital setting, which include excessive wait ... hospital staff. Commenting on this article, the founder of House Call Doctor Los ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... 2016 Champion Award to Charles D. Pulido, R.Ph., Co-Founder of NCPDP and member ... Ph.D., Pharmacy Advisor and Health IT Specialist, Office of the National Coordinator for ...
(Date:5/3/2016)... Redondo Beach, CA (PRWEB) , ... May 03, 2016 , ... ... together online to help cancer patients and their families move toward recovery and is ... the focus of today's Dr. Carol Francis Talk Radio show considering medical ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... YORK , May 2, 2016 Kalorama ... EMR (Electronic Medical Records) market in a recent white ... sales, vendor switches, Increased physician usage, a growing market are ... were noted in Kalorama,s report EMR 2016: ... report marks Kalorama,s seventh complete study of the EMR ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
Breaking Medicine Technology: